Defining the Role of PCSK9 Inhibitors in the Treatment of Hyperlipidemia Thomas F. Whayne Jr. Current Opinion 23 November 2015 Pages: 83 - 92
Addressing Major Unmet Needs in Patients with Systolic Heart Failure: The Role of Ivabradine Antonio Carlos Pereira-Barretto Review Article Open access 27 January 2016 Pages: 93 - 101
Meta-Analysis of Oral Anticoagulants with Dual versus Single Antiplatelet Therapy in Patients after Percutaneous Coronary Intervention Alexandros BriasoulisNikolaos PapageorgiouDimitris Tousoulis Systematic Review 09 December 2015 Pages: 103 - 110
Prolonged Clopidogrel Use is Associated with Improved Clinical Outcomes Following Drug-Eluting But Not Bare Metal Stent Implantation Nicholas L. CrudenJehangir N. DinSimon D. Robinson Original Research Article 09 January 2016 Pages: 111 - 118
Effect of Rifampin on the Pharmacokinetics of Apixaban, an Oral Direct Inhibitor of Factor Xa Blisse VakkalagaddaCharles FrostFrank LaCreta Original Research Article 09 January 2016 Pages: 119 - 127
Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial Il Suk SohnChong-Jin KimFor the Investigators Original Research Article Open access 21 December 2015 Pages: 129 - 138
Erratum to: Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial Il Suk SohnChong-Jin KimFor the Investigators Erratum 18 March 2016 Pages: 139 - 139
Alirocumab: A Review in Hypercholesterolemia Sarah L. GreigEmma D. Deeks Adis Drug Evaluation 02 March 2016 Pages: 141 - 152
